About: Jacques Touchon

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Jacques Touchon Goto Sponge NotDistinct Permalink

An Entity of Type : foaf:Person, within Data Space : data.idref.fr associated with source document(s)

Attributes	Values
type	Person
sameAs	Touchon, Jacques (1946-....) Touchon, Jacques (1946-....) Touchon, Jacques (1946-....) Touchon, Jacques (1946-....)
Life Event	http://www.idref.fr/032090900/birth
bnf-onto:FRBNF	12318807(xsd:integer)
preferred label	Touchon, Jacques (1946-....)
name	Jacques Touchon
dbpedia-owl:citizenship	http://sws.geonames.org/3017382/
Language	http://lexvo.org/id/iso639-3/fra
isni:identifierValid	0000000066466859
Given name	Jacques
familyName	Touchon
has biographical i...tion (Deprecated)	Médecin, spécialisé en neurologie Médecin à Unité de neurologie comportementale - Gui de Chauliac ; Directeur de l'UFR de médecine de l'université Montpellier 1 en 2005
gender	male
Scopus ID	7004526419
is sameAs of	Touchon, Jacques (1946-....)
is Thesis advisor of	http://www.sudoc.fr/121802620/id http://www.sudoc.fr/094256756/id http://www.sudoc.fr/103954430/id http://www.sudoc.fr/075680769/id http://www.sudoc.fr/095819991/id http://www.sudoc.fr/12724705X/id http://www.sudoc.fr/010173528/id http://www.sudoc.fr/013433059/id http://www.sudoc.fr/048218626/id http://www.sudoc.fr/005404665/id http://www.sudoc.fr/07900816X/id http://www.sudoc.fr/079014046/id http://www.sudoc.fr/011475862/id http://www.sudoc.fr/004732480/id http://www.sudoc.fr/246897562/id De l'inhibition contrôlée au contrôle de l'inhibition, une approche fonctionnelle du déficit lors du vieillissement http://www.sudoc.fr/24686429X/id Détection des troubles cognitifs légers (MCI), algorithmes diagnostiques, dépistage et validité prédictive Troubles de la cognition dans la neurodégénérescence, intérêt prédictif des paramètres neuropsychologiques, fonctionnels, électrophysiologiques et génétiques, application à la SLA et à la maladie d'Alzheimer Isoprostanes : de la méthodologie à la clinique. Place potentielle dans l'exploration du diabète et des pathologies associées au vieillissement http://www.sudoc.fr/246744839/id http://www.sudoc.fr/246744707/id
is Author of	http://www.sudoc.fr/127107509/id http://www.sudoc.fr/003657914/id http://www.sudoc.fr/130934240/id http://www.sudoc.fr/060546891/id La maladie d'Alzheimer http://www.sudoc.fr/053127250/id http://www.sudoc.fr/082605874/id The reference site of the European Innovation Partnership on Active and Healthy Aging MACVIA-LR (the fight against chronic diseases for an active and healthy aging in Languedoc-Roussillon) https://hal.archives-ouvertes.fr/hal-01756497#id Validation of AclarusDx™, a blood-based transcriptomic signature for the diagnosis of Alzheimer's disease. Validation of AclarusDx™, a blood-based transcriptomic signature for the diagnosis of Alzheimer's disease. les corrélats neuronaux de l'acquisition et de la consolidation dans la maladie d'alzheimer et l'altération cognitive légère Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study [The Esprit Project: a longitudinal general population study of psychiatric disorders in France in subjects over 65 years old] Limiting Factors of Brain Donation in Neurodegenerative Diseases: The Example of French Memory Clinics Chiari malformation and sleep related breathing disorders Registries and Cohorts to Accelerate Early Phase Alzheimer's Trials. A Report from the E.U./U.S. Clinical Trials in Alzheimer's Disease Task Force. Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer’s Disease Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study Recruitment strategies for preventive trials. The MAPT study (MultiDomain Alzheimer Preventive Trial). Living Lab MACVIA-LR Fragilité Cognitive Event-Related Potential, an Early Diagnosis Biomarker in Frail Elderly Subjects: The ERP-MAPT-PLUS Ancillary Study Correlations between soluble alpha/beta forms of amyloid precursor protein and Abeta38, 40 and 42 in human cerebrospinal fluid Risk of Alzheimer's disease biological misdiagnosis linked to cerebrospinal collection tubes. https://archive-ouverte.unige.ch/unige:31894#id Recruitment strategies for preventive trials. The MAPT study (MultiDomain Alzheimer Preventive Trial Metabolic syndrome, its components, and mortality in the elderly. Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study. Recommendations for the use of Serious Games in people with Alzheimer's Disease, related disorders and frailty. Plasma Amyloid-β Levels and Prognosis in Incident Dementia Cases of the 3-City Study. Spatial distribution of cerebral white matter lesions predicts progression to mild cognitive impairment and dementia. http://www.sudoc.fr/250227479/id Introduction Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of Alzheimer's disease. Valeur prototypique des intrusions sémantiques dans la maladie d’Alzheimer Plasma β-amyloid 40 levels are positively associated with mortality risks in the elderly. Risk profiles for mild cognitive impairment and progression to dementia are gender specific. Intérêts de la musicothérapie sur l’anxiété, la dépression des patients atteints de la maladie d’Alzheimer et sur la charge ressentie par l’accompagnant principal (étude de faisabilité) Palmomental reflex a relevant sign in early Alzheimer's disease diagnosis? Revised Criteria for Mild Cognitive Impairment: Validation within a Longitudinal Population Study. Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer’s Disease Risk profiles for mild cognitive impairment and progression to dementia are gender specific Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial Operational definition of Active and Healthy Ageing (AHA): A conceptual framework Long-term use of standardised ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers Collaborative efforts to prevent Alzheimer’s disease Prevention of progression to dementia in the elderly: Rationale and proposal for a health-promoting memory consultation (an IANA task force) http://www.sudoc.fr/033951527/id Group and individual cognitive therapies in Alzheimer's disease: the ETNA3 randomized trial Utility of the Mattis dementia rating scale to assess the efficacy of rivastigmine in dementia associated with Parkinson's disease. Rapid cognitive decline in Alzheimer's disease. Consensus paper. Insomnia symptoms in older adults: associated factors and gender differences. Measuring cognitive change in subjects with prodromal Alzheimer's disease. Education Modulates the Impact of White Matter Lesions on the Risk of Mild Cognitive Impairment and Dementia. http://www.sudoc.fr/221764887/id An overview of the use of music therapy in the context of alzheimer's disease: a report of a french expert group Analysing time to event data in dementia prevention trials: The example of the guidage study of EGB761® War exposure, 5-HTTLPR genotype and lifetime risk of depression.

Faceted Search & Find service v1.13.91 as of Aug 16 2018

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software